Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bernd Kasper, MD
Mannheim University Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cliniques Universitaires Saint-Luc, Institut Roi Albert Ii
Brussels, Belgium
- Institut Jules Bordet-Medical Oncology
Brussels, Belgium
- Uz Gent
Ghent, Belgium
- Uz Leuven
Leuven, Belgium
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Mcgill University Health Centre
Montreal, Quebec, Canada
- Helios Klinikum Berlin-Buch
Berlin, Germany
- Universitaetsklinikum Hamburg-Eppendorf
Hamburg, Germany
- Universitätsmedizin Mannheim
Mannheim, Germany
- Irccs Istituto Ortopedico Rizzoli
Bologna, Italy
- Istituto Di Candiolo Irccs Oncologia Medica
Candiolo, Italy
- Fondazione Irccs Instituto Nazionale Dei Tumori Di Milano
Milan, Italy
- Policlinico Unvrsitario Campus Bio-Medico
Roma, Italy
- Radboud University Medical Centre
Nijmegen, Gelderland, Netherlands
- the Netherlands Cancer Institute
Amsterdam, Netherlands
- Leiden University Medical Center (lumc)
Leiden, Netherlands
- Department of Oncology, University College of London Hospital
London, United Kingdom
- the Royal Marsden Nhs Foundation Trust
London, United Kingdom
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Ronald Regan Ucla Medical Center
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- Stanford Cancer Center
Palo Alto, California, United States
- Ucsf Mission Bay
San Francisco, California, United States
- Sarcoma Oncology Research Center
Santa Monica, California, United States
- University of Colorado Hospital-Anschutz Cancer Pavilion (acp)
Aurora, Colorado, United States
- Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut, United States
- Washington Cancer Institute at Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Northwestern Memorial Hospital
Chicago, Illinois, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute (dfci)
Boston, Massachusetts, United States
- Massachusetts General Hosptial (mgh)
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Northwell Health
Lake Success, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Dumc/duke Cancer Center
Durham, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Apr 2019
- Primary completion
- 7 Apr 2022
- Completion
- 17 Oct 2024
- Last update posted
- 31 Jan 2025
- Registered enrollment
- 142
- Registry id
- NCT03785964
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.